Phase-3 Clinical Trials of Adjunctive Therapy with Preladenant, an Adenosine 2a Antagonist, in Patients with Parkinson’s Disease (P7.087)Robert A. Hauser, David Hewitt, Xianwei Ha et al.|Neurology|2014Cited by 13
Post-hoc Analyses of Phase-3 Data with Preladenant, an Adenosine 2a Antagonist, in Patients with Parkinson’s Disease (P7.088)Olivier Rascol, Susan Huyck, Robert A. Hauser et al.|Neurology|2014Cited by 1